Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Our Compounding Knowledge, Your Peace of Mind
April 27, 2018  |  Volume 15  |  Issue 17
IN THIS ISSUE
 
SUBSCRIPTIONS / INFO
 
CLASSIFIEDS
 
ABOUT COMPOUNDINGTODAY
 
FREE RESOURCES
 
SUBSCRIBER RESOURCES
IJPC: Our Compounding Knowledge - Your Peace of Mind!
Particle Measuring Systesm - Meet USP <797> Environmental Requirements With Easy to Use Solutions
 
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
<795> Pharmaceutical Compounding—Nonsterile Preparations

This newsletter is a continuation of our series on the proposed USP <795> Pharmaceutical Compounding—Nonsterile Preparations. Here, we look at some comments on selected aspects of Sections 1 and 2. The numbers on the left are the same as those actually in the chapter. Only those items with comments are reproduced. In other words, there are no comments for those lines not printed, they appear to be fine.

1. INTRODUCTION AND SCOPE

Defines Nonsterile Compounding:

Nonsterile compounding is defined as:

5 Combining, admixing, diluting, pooling, reconstituting other than as provided
6in the manufacturer package insert, or otherwise altering a drug or bulk drug
7substance to create a nonsterile medication. Reconstituting a conventionally
8manufactured nonsterile product in accordance with the directions contained
9in the approved labeling provided by the product's manufacturer is not
10considered compounding as long as the product is prepared for an individual
11patient and not stored for future use.
 
+Is it a requirement that the individual reconstituting the manufactured product wear gloves, mask, etc.? Oftentimes, antibiotics for reconstitution release powders into the air when opened for reconstitution. Seems potentially problematic�especially if the compounder may have respiratory issues. Even though it is understandable to omit them here, the problem still exists and possibly manufacturers should be required to add a labeling statement.
 
+�not stored for future use�needs clarification. Is it really necessary? In the antibiotic reconstitution example, it is generally stored and administered over 14 days. The way it reads can be interpreted for immediate use.
 
121.1 Scope
 
13COMPOUNDED NONSTERILE PREPARATIONS AFFECTED
 
27AFFECTED PERSONNEL AND SETTINGS
 
28This chapter applies to all persons who prepare CNSPs and all places where
29CNSPs are prepared. This includes but is not limited to pharmacists,
30technicians, physicians, veterinarians, dentists, naturopaths, chiropractors,
31and nurses, in all places including but not limited to pharmacies, hospitals
32and other healthcare institutions, patient treatment sites, and physicians' or
33veterinarians' practice sites.
 
+For non pharmacists/technicians, this is not realistic and most likely will not be implemented in states. Non-pharmacist professionals don't generally fall under the state boards of pharmacy and the specific professional boards of those professions see these standards, as well as those of 800, as problematic and will ignore them, as they have for other pharmacy professional practice standards. Recommend limiting the proposed chapter to pharmacy facilities.
 
34The compounding facility's leadership and all personnel involved in
35preparing, storing, packaging, and transporting CNSPs are responsible for 1)
36ensuring that the applicable practices and quality standards in this chapter
37are continually and consistently applied to their operations, and 2)
38proactively identifying and remedying potential problems within their
39operations. Personnel engaged in the compounding of CNSPs must also
40comply with applicable laws and regulations of the regulatory jurisdiction.
41The compounding facility must designate one or more individuals (i.e., the
42designated person) to be responsible and accountable for the performance
43and operation of the facility and personnel in the preparation of CNSPs. The
44responsibilities of the designated person include but are not limited to:
45• Developing and implementing a training program
46• Routinely monitoring and observing compounding activities and taking
47  immediate corrective action if deficient practices are observed
48• Demonstrating the procedures for personnel and observing and
49  guiding personnel throughout the training process
50• Evaluating whether individuals with certain conditions, such as rashes
51  or respiratory illnesses, will be allowed to work in compounding areas
 
+Difficult to understand where "dry" rashes on the trunk, back, legs, etc. would be problematic here. Needs clarification. Possibly just limit to respiratory conditions, rashes in exposed areas, weeping rashes or those that may be contagious?
 
52before their conditions are resolved because these conditions carry
53the risk of contaminating the environment and CNSPs
 
+This last part of the entire sentence is not necessary as it is common knowledge.
 
+It seems these standards are aimed at large and very large compounding facilities. However, many are small operations and all these standards may involve only one person doing the compounding.
 
622. PERSONNEL QUALIFICATIONS-TRAINING, EVALUATION, AND
63    REQUALIFICATION
 
+Seems like a lot of this came from 797, but that is fine�.they will be somewhat harmonized.
 
+There is no discussion or apparent allowance for training variances as to the type and extent of training for different sites. If only doing minimal "low-risk" compounding, why is it necessary to be trained in more technical and detailed compounding. The type and extent of training should be commensurate with the type and extent of compounding being done.


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

 

Did You Know ...

�that Will Rogers stated the following?:

"If you find yourself in a hole, the first thing to do is to stop digging."

 

Tip of the Week

It seems it's human nature that when we are confronted with an error or adverse situation, we try to justify our actions and sometimes make things up�when the best thing to do is to admit it, correct it, and go on.

 

IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

View our growing collection of educational and training videos at www.ijpc.com/video or by subscribing to our Youtube channel at https://www.youtube.com/IJPCompounding.

 

Looking Back

Dewhiskered kisses,
Defrost the Misses.
     Burma Shave

Copyright 2018
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com